CD34 and classic Hodgkin lymphoma: In this study, we focused on investigating gene mutations in BM CD34+ cells, which account for 1–2% of the total BM cells in healthy individuals [8] and about 2–3% in cHL patients, therefore, the common gene mutations were absent.